New treatment strategy allows lower doses of toxic tuberculosis drug without compromising potency

While an effective treatment is available for combating multidrug-resistant tuberculosis, it carries serious side effects for patients. New research shows that lower doses of the toxic drug bedaquiline — given together with verapamil, a medication that’s used to treat various heart conditions — can lead to the same antibacterial effects as higher toxic doses of bedaquiline.

Read the whole article on Science Daily

More from Science Daily